NTLA
Intellia Therapeutics Inc
Price:  
7.88 
USD
Volume:  
3,419,439.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NTLA Stock Forecast & Price Target

NTLA Stock Price Forecast

The average stock forecast for Intellia Therapeutics Inc (NTLA) in the next 12 months is 42.50 USD. This price target corresponds to an upside of 439.34%. The range of stock forecasts for NTLA is 8.08 - 111.30 USD. Based on the ratings of 34 analysts, the consensus recommendation for NTLA is BUY.
Target Low Average Median High
Price (USD) 8.08 42.50 41.82 111.30
Upside 2.54% 439.34% 430.71% 1,312.44%

Recommendation Trends

The latest consensus rating for NTLA is "BUY". This is the average recommendation of 34 analysts: 0 strong sell, 1 sell, 7 hold, 16 buy, 10 strong buy. In the previous period, 34 analysts also majorly recommmended "BUY" for NTLA.

NTLA Financial Stock Forecast

Revenue This Year
55.62M
-3.90%
from 57.88M
Revenue Next Year
50.46M
-9.28%
from 55.62M
EPS This Year
-4.76
-9.34%
from -5.25
EPS Next Year
-4.60
-3.37%
from -4.76